Skip to content

The Impact of P-AC and BIPAP Mechanical Ventilation Modes on Diaphragmatic Function in Patients with Autonomous Breathing

The Impact of P-AC and BIPAP Mechanical Ventilation Modes on Diaphragmatic Function in Patients with Autonomous Breathing

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111813
Enrollment
Unknown
Registered
2025-11-06
Start date
2025-11-25
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical ventilation for critically ill patients

Interventions

BIPAP Invasive Mechanical Ventilation Mode:BIPAP Invasive Mechanical Ventilation Mode
P-AC Invasive Mechanical Ventilation Mode:P-AC Invasive Mechanical Ventilation Mode

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 to 80 years; 2. Expected mechanical ventilation duration >=48 hours; 3. Skin integrity over the diaphragm ultrasound detection area is fully exposed; 4. Patients or their families have provided informed consent to participate in the clinical trial and voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with absent spontaneous breathing due to disease; 2. Patients with neuromuscular disorders, such as Guillain-Barré syndrome or myasthenia gravis, causing diaphragmatic dysfunction; 3. Patients with anatomical diaphragmatic abnormalities or unilateral diaphragmatic dysfunction; 4. Patients where diaphragm measurement is impossible via ultrasound, such as those with pneumothorax, excessive body weight, pregnancy, seizures, or abdominal compartment syndrome; 5. Patients with >48 hours of mechanical ventilation within 6 months prior to admission; 6. Patients on fully controlled ventilation mode; 7. Patients judged by clinicians to have poor short-term prognosis, i.e., those receiving palliative care, severely debilitated, with critical hemodynamic instability, requiring end-of-life resuscitation, or highly likely to die within seven days; 8. Patients with primary pulmonary diseases severely impairing lung function, such as tumors, severe ARDS (oxygenation index < 100), active pulmonary tuberculosis, or pleural thickening and adhesions; 9. Patients with secondary diseases severely impairing lung function that cause acute exacerbation of pulmonary symptoms.

Design outcomes

Primary

MeasureTime frame
Diaphragm thickening score;

Countries

China

Contacts

Public ContactJing Tang

The First Hospital of Jilin University

280453745@qq.com+86 139 4494 9944

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026